Literature DB >> 9824009

Pulmonary aspergillosis in cystic fibrosis lung transplant recipients.

D R Nunley1, P Ohori, W F Grgurich, A T Iacono, P A Williams, R J Keenan, J H Dauber.   

Abstract

STUDY
OBJECTIVE: To define the prevalence of colonization and infection of the lower respiratory tract (LRT) with Aspergillus in lung transplant recipients with and without cystic fibrosis (CF).
DESIGN: Retrospective review.
SETTING: Large university lung transplant center.
MATERIALS AND METHODS: The postoperative course of 31 CF and 53 non-CF double lung or double lobar transplant recipients receiving allografts from April 1991 to February 1996 was reviewed. All recipients were subjected to surveillance bronchoscopy and biopsy at predetermined intervals and when clinically indicated. BAL fluid (BALF) and biopsy material were examined by appropriate fungal culture and staining techniques. Infection was defined by the finding of tissue-invasive disease on biopsy specimens.
RESULTS: Seven of the 31 CF recipients (22%) had Aspergillus isolated from cultures of sputum prior to transplantation. Following transplantation, 15 CF recipients (48%) had Aspergillus isolated from either sputum or BALF, including 4 of the 7 recipients identified with the fungus prior to transplantation. By contrast, 21 of the 53 non-CF recipients (40%) had Aspergillus isolated from the LRT following transplantation, none having had the fungus isolated prior to transplantation. The prevalence of Aspergillus did not differ between these groups (p = 0.51). Infections with Aspergillus occurred in 4 of the CF recipients (27%) and did not differ from the 3 infections (14%) identified in the non-CF recipients (p = 0.36). However, three of the four infections in the CF recipients involved the healing bronchial anastomosis and occurred prior to postoperative day 60. All three of these recipients had Aspergillus preoperatively. Postoperative infection was more common in the CF recipients having Aspergillus preoperatively than in those CF recipients without preoperative Aspergillus (p = 0.02).
CONCLUSIONS: Isolation of Aspergillus from the LRT following double lung transplantation is common and generally not associated with tissue-invasive disease. Those CF recipients with Aspergillus isolated in cultures of sputum preoperatively are at risk for postoperative infections with this agent. The healing bronchial anastomosis is particularly vulnerable.

Entities:  

Mesh:

Year:  1998        PMID: 9824009     DOI: 10.1378/chest.114.5.1321

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis.

Authors:  R C Barton; A M Borman; E M Johnson; J Houbraken; R P Hobson; M Denton; S P Conway; K G Brownlee; D Peckham; T W R Lee
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 3.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 4.  Fungal infections in lung transplantation.

Authors:  Palash Samanta; Cornelius J Clancy; M Hong Nguyen
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

5.  Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.

Authors:  Palash Samanta; Cornelius J Clancy; Rachel V Marini; Ryan M Rivosecchi; Erin K McCreary; Ryan K Shields; Bonnie A Falcione; Alex Viehman; Lauren Sacha; Eun Jeong Kwak; Fernanda P Silveira; Pablo G Sanchez; Matthew Morrell; Lloyd Clarke; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

Review 6.  Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors:  Judith A Anesi; John W Baddley
Journal:  Infect Dis Clin North Am       Date:  2015-12-28       Impact factor: 5.982

7.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

8.  Impact of mold infections in explanted lungs on outcomes of lung transplantation.

Authors:  Aniket Vadnerkar; Cornelius J Clancy; Umit Celik; Samuel A Yousem; Dimitra Mitsani; Yoshiya Toyoda; Minh-Ly Nguyen; Eun J Kwak; Joseph Pilewski; Fernanda P Silveira; Maria Crespo; M Hong Nguyen
Journal:  Transplantation       Date:  2010-01-27       Impact factor: 4.939

Review 9.  Pediatric lung transplantation: promise being realized.

Authors:  Carol Conrad; David N Cornfield
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

Review 10.  Tracheobronchial manifestations of Aspergillus infections.

Authors:  Rafal Krenke; Elzbieta M Grabczak
Journal:  ScientificWorldJournal       Date:  2011-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.